Plasma stromal cell-derived factor 1 alpha/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease Article

Ghasemzadeh, Nima, Hritani, Abdul Wahab, De Staercke, Christine et al. (2015). Plasma stromal cell-derived factor 1 alpha/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease . ATHEROSCLEROSIS, 238(1), 113-118. 10.1016/j.atherosclerosis.2014.10.094

Open Access

cited authors

  • Ghasemzadeh, Nima; Hritani, Abdul Wahab; De Staercke, Christine; Eapen, Danny J; Veledar, Emir; Al Kassem, Hatem; Khayata, Mohamed; Zafari, A Maziar; Sperling, Laurence; Hooper, Craig; Vaccarino, Viola; Mavromatis, Kreton; Quyyumi, Arshed A

sustainable development goals

authors

publication date

  • January 1, 2015

webpage

published in

keywords

  • CXCL12
  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Cardiovascular outcomes
  • Coronary artery disease
  • FACTOR-1-ALPHA
  • FACTOR-I
  • HEART
  • INVOLVEMENT
  • Life Sciences & Biomedicine
  • MIGRATION INHIBITORY FACTOR
  • MYOCARDIAL-INFARCTION
  • PROGENITOR CELLS
  • Peripheral Vascular Disease
  • RECRUITMENT
  • RISK
  • STEM
  • Science & Technology
  • Stromal cell-derived factor1 alpha

publisher

  • ELSEVIER IRELAND LTD

start page

  • 113

end page

  • 118

volume

  • 238

issue

  • 1